
Auth57 · Specialty PA Pack
Neurology
For the neurologist managing MS and migraine therapies — coverage, criteria, and appeals across all 51 states.
Structured rules
1,002
PA-required
99%
Appeal layer
51/51
Criteria docs
44/51
The breadth · all 51 jurisdictions
Every state, quantified for neurology
| State | Rules | PA-required | Appeal | Criteria docs |
|---|---|---|---|---|
| AKAlaska | 13 | 100% | ✓ | 2 |
| ALAlabama | 21 | 100% | ✓ | 6 |
| ARArkansas | 23 | 100% | ✓ | 2 |
| AZArizona | 21 | 100% | ✓ | 6 |
| CACalifornia | 23 | 96% | ✓ | 7 |
| COColorado | 21 | 95% | ✓ | 10 |
| CTConnecticut | 21 | 100% | ✓ | 3 |
| DCDistrict of Columbia | 21 | 95% | ✓ | 9 |
| DEDelaware | 20 | 100% | ✓ | 3 |
| FLFlorida | 21 | 100% | ✓ | — |
| GAGeorgia | 23 | 96% | ✓ | 12 |
| HIHawaii | 21 | 95% | ✓ | 5 |
| IAIowa | 21 | 100% | ✓ | 6 |
| IDIdaho | 15 | 100% | ✓ | 1 |
| ILIllinois | 20 | 100% | ✓ | — |
| INIndiana | 21 | 100% | ✓ | 2 |
| KSKansas | 20 | 100% | ✓ | 11 |
| KYKentucky | 23 | 100% | ✓ | 3 |
| LALouisiana | 19 | 100% | ✓ | 9 |
| MAMassachusetts | 17 | 100% | ✓ | 1 |
| MDMaryland | 19 | 95% | ✓ | 9 |
| MEMaine | 19 | 100% | ✓ | 3 |
| MIMichigan | 19 | 100% | ✓ | 6 |
| MNMinnesota | 15 | 100% | ✓ | 2 |
| MOMissouri | 25 | 100% | ✓ | 1 |
| MSMississippi | 23 | 100% | ✓ | 8 |
| MTMontana | 15 | 100% | ✓ | 2 |
| NCNorth Carolina | 23 | 100% | ✓ | 6 |
| NDNorth Dakota | 15 | 100% | ✓ | — |
| NENebraska | 19 | 100% | ✓ | 3 |
| NHNew Hampshire | 19 | 100% | ✓ | — |
| NJNew Jersey | 19 | 100% | ✓ | 3 |
| NMNew Mexico | 15 | 100% | ✓ | 3 |
| NVNevada | 19 | 100% | ✓ | 16 |
| NYNew York | 21 | 100% | ✓ | 3 |
| OHOhio | 23 | 100% | ✓ | 14 |
| OKOklahoma | 23 | 100% | ✓ | — |
| OROregon | 22 | 95% | ✓ | 3 |
| PAPennsylvania | 19 | 100% | ✓ | 8 |
| RIRhode Island | 15 | 100% | ✓ | — |
| SCSouth Carolina | 21 | 100% | ✓ | 7 |
| SDSouth Dakota | 13 | 100% | ✓ | — |
| TNTennessee | 21 | 100% | ✓ | 4 |
| TXTexas | 23 | 100% | ✓ | 39 |
| UTUtah | 21 | 100% | ✓ | 11 |
| VAVirginia | 23 | 96% | ✓ | 5 |
| VTVermont | 13 | 100% | ✓ | 6 |
| WAWashington | 23 | 100% | ✓ | 6 |
| WIWisconsin | 21 | 100% | ✓ | 3 |
| WVWest Virginia | 16 | 100% | ✓ | 1 |
| WYWyoming | 15 | 100% | ✓ | 5 |
Free preview· Texas
What a fully-unlocked state looks like
medicaid ffs
- ms disease modifyingPA requiredCorrected to PA-required via cross-state consensus + source re-verification: clinical judgment, low confidence (no source); 95% cross-state norm
- migraine cgrpPA requiredTX Medicaid PDL: non-preferred agents require PA (step therapy). Source: Acentra TX PDL Criteria Guide 2026-01-30 (official companion to TX Medicaid PDL).
commercial regulated
- ms disease modifying(UnitedHealthcare)PA requiredUnitedHealthcare commercial (Advantage 3-Tier). CNS-multiple sclerosis; all agents carry PA+QL+SP (MAVENCLAD adds ST) [e.g. AVONEX, KESIMPTA, MAVENCLAD, MAYZENT]
- migraine cgrp(UnitedHealthcare)PA requiredUnitedHealthcare commercial (Advantage 3-Tier). Antimigraine-migraines; CGRP agents (AIMOVIG, NURTEC, QULIPTA, UBRELVY, ZAVZPRET) carry PA+ST+QL; triptans QL only [e.g. AIMOVIG, EMGALITY, NURTEC, QULIPTA]
- ms disease modifying(Cigna)PA requiredCigna commercial (Advantage 3-Tier). MS DMTs SP, injectables/orals PA (generics SP only) [e.g. AVONEX, KESIMPTA, MAYZENT, VUMERITY]
- migraine cgrp(Cigna)PA requiredCigna commercial (Advantage 3-Tier). CGRP mAbs and gepants carry PA [e.g. AIMOVIG, AJOVY, EMGALITY, NURTEC ODT]
- migraine cgrp(Aetna (CVS Caremark))PA requiredAetna (CVS Caremark) commercial formulary. CGRP monoclonal antibodies, specialty PA/ST [e.g. AIMOVIG, EMGALITY, AJOVY (CGRP mAbs)]
- migraine cgrp(Anthem Blue Cross (Elevance))PA requiredAnthem Blue Cross (Elevance) commercial formulary. CGRP receptor antagonist monoclonal antibodies: PA + QL [e.g. EMGALITY galcanezumab, CGRP monoclonal antibodies]
- ms disease modifying(Anthem Blue Cross (Elevance))PA requiredAnthem Blue Cross (Elevance) commercial formulary. MS agents (interferons, NRF2, pyrimidine synthesis, K-channel blockers, oral): PA + SP; monoclonal abs vary [e.g. teriflunomide, dimethyl fumarate, interferon beta, TYSABRI natalizumab]
part d
- migraine cgrp(Centene)PA requiredCentene Part D (CMS formulary file, plan-grounded).
- ms disease modifying(Centene)PA requiredCentene Part D (CMS formulary file, plan-grounded).
- migraine cgrp(Unitedhealthcare)PA requiredUnitedhealthcare Part D (CMS formulary file, plan-grounded).
- ms disease modifying(Unitedhealthcare)PA requiredUnitedhealthcare Part D (CMS formulary file, plan-grounded).
- migraine cgrp(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
- ms disease modifying(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
- migraine cgrp(Cigna)PA requiredCigna Part D (CMS formulary file, plan-grounded).
- ms disease modifying(Cigna)PA requiredCigna Part D (CMS formulary file, plan-grounded).
- migraine cgrp(Aetna)PA requiredAetna Part D (CMS formulary file, plan-grounded).
- ms disease modifying(Aetna)PA requiredAetna Part D (CMS formulary file, plan-grounded).
commercial qhp
- migraine cgrp(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
- ms disease modifying(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
- migraine cgrp(Molina Healthcare)PA requiredMolina Healthcare commercial formulary. Ubrelvy/Ajovy/Emgality (gepants + CGRP mAbs) carry PA
- ms disease modifying(Molina Healthcare)PA requiredMolina Healthcare commercial formulary. MS agents, interferons, and pyrimidine-synthesis inhibitor all PA
If denied in Texas
📨 Program Support Unit (PSU)
Unlock the full pack
Full criteria, sources & appeal paths — all 51 states.
You’ve seen the breadth and one state in full. The complete Neurologypack — every state’s criteria, source citations, and step-by-step appeal instructions — is one email away.
Assembled from Auth57’s rules + criteria corpus + 51-state appeal layer. Draft data — verify against the payer’s current policy before relying.